Skip to main content
SpringerLink
Log in

Proton Magnetic Resonance Spectroscopy in Portal-Systemic Encephalopathy

  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

Localized proton magnetic resonance spectroscopy (MRS) with short echo times provides unique information of human cerebral metabolism. Studies on patients with portal-systemic encephalopathy (PSE) have been performed to clarify the pathogenesis of this disease and to find a method which allows an objective diagnosis. Spectra of patients with PSE show typical abnormalities. Regional variations of these spectral changes are observed. The metabolic changes correlate with the grade of encephalopathy but the dependence on the Child-Pugh score is controversial. No causal dependence between MRS findings and abnormalities in magnetic resonance imaging is evident. Differences in magnetic resonance spectra in patients compared to controls vanish after liver transplantation, but increase after TIPS. The results of proton magnetic resonance spectroscopy are important for an understanding of the pathogenesis of PSE, but do not aid in the diagnosis of subclinical hepatic encephalopathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  • Becker, G., Rohr, G., Gückel, F., Holm, E., Loose, R. and Georgi, M. (1994). Follow up of hepatic encephalopathy by localized proton MR spectroscopy of the human brain [abstract]. Soc Magn. Reson. 2:570.

    Google Scholar 

  • Bottomley, P.A. (1987). Spatial localization in NMR-spectroscopy in vivo. Proc. NY Acad. Sci. 508:333–348.

    Google Scholar 

  • Bottomley, P.A. (1992). Proton MR spectroscopy for diagnosing hepatic encephalopathy. Radiol. 182:6–7.

    Google Scholar 

  • Bruhn, H., Frahm, J., Michaelis, T., Merboldt, K.D., Hänicke, W., Gyngell, M.L. et al. (1991a). Metabolic disturbances of the brain in patients with liver cirrhosis detected by proton magnetic resonance spectroscopy [abstract]. Hepatol. 14:121.

    Google Scholar 

  • Bruhn, H., Merboldt, K.D., Michaelis, T., Gyngell, M.L., Hänicke, W., Frahm, J. et al. (1991b). Proton MRS of metabolic disturbances in the brain of patients with liver cirrhosis and subclinical hepatic encephalopathy [abstract]. Soc. Magn. Reson. Med. 10:400.

    Google Scholar 

  • Brunberg, J.A. Kanal, E., Hirsch, W. and Van Thiel, D.H. (1993). Chronic acquired hepatic failure: MR imaging of the brain at 1.5 T. AJNR 12:909–914.

    Google Scholar 

  • Butterworth, R.F., Giguere, J.F., Michaud J. and Layrargues, G.P. (1987). Ammonia: key factor in the pathogenesis of hepatic encephalopathy. Neurochem. Pathol. 6:1–12.

    Google Scholar 

  • Chamuleau, R., Bosman, D.K., Bovée, W., Luyten, P.R. and den Hollander, J.A. (1991). What the clinician can learn from MR glutamine/glutamate assays. NMR in Biomedicine 4:103–108.

    Google Scholar 

  • Chamuleau, R., Bosman, D.K., Bovée, W., Luyten, P.R., den Hollander, J.A. (1994). In vivo brain magnetic resonance imaging (MRI) and magnetic resonance spectroscopy in hepatic encephalopathy. In (V. Felipo, S. Grisolia, eds.) Hepatic Encephalopathy, Hyperammonia, and Ammonia Toxicity, Plenum Press, New York, pp. 23–31.

    Google Scholar 

  • Danielsen, E.R., Ernst, T., Geissler, A., Villamil, F., Michaelis, T. and Ross, B.D. (1995). Is hepatic encephalopathy a disturbance of cerebral osmolytes? [abstract]. Soc. Magn. Resan. 3:1839.

    Google Scholar 

  • Frahm, J., Merboldt, K.D. and Hänicke, W. (1987). Localized proton spectroscopy using stimulated echoes. J. Magn. Reson. 72:502.

    Google Scholar 

  • Frahm, J., Bruhn, H., Michaelis, T., Merboldt, K.D., Hänicke, W. and Gyngell, M.L. (1991) Localized proton MR spectroscopy. Radiol. 31:558–566.

    Google Scholar 

  • Geissler, A., Farrow, N.A., Villamil, F., Makowka, L., Ernst, T., Kreis, R. and Ross, B.D. (1992). Is hepatic encephalopathy reversed by liver transplantation? [abstract]. Soc. Magn. Reson. Med. 11:6–47.

    Google Scholar 

  • Geissler, A., Lock, G., Fründ, R., Held, P., Hollerbach, S., Andus, T. et al. (1997). Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging. Hepatol. 25:48–54.

    Google Scholar 

  • Granot, J. (1986). Selected volume excitation using stimulated echoes (VEST) — Applications to spatially localized spectroscopy and imaging. J. Magn. Reson. 70:488–492.

    Google Scholar 

  • Hanner, J.S., Li, K.C.P. and Davis, G.L. (1988). Acquired hepatocerebral degeneration: MR similarity with Wilson disease. J. Comp. Ass. Tomograph. 12:1076–1077.

    Google Scholar 

  • Haseler, L.J., Agarwal, V., Sibbitt, W.L., Brooks, W.M., Hart, B.L. and Matwiyoff, N.A. (1992). Chronic hepatic encephalopathy: reversal of 1H MR spectra following liver transplantation [abstract]. Soc. Magn. Reson. Med. 11:1014.

    Google Scholar 

  • Häussinger, D., Laubenberger, J., Vom Dahl, S., Ernst, T., Bayer, S., Langer, M. et al. (1994). Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. Gastroenterol. 107:1475–1480.

    Google Scholar 

  • Huda, A., Thomas, A., Bugbee, M., Ke, Y., Oshiro, T., Strouse, T., Curran, J. and Guze, B. (1995). Regional variations of metabolites in hepatic encephalopathy [abstract]. Soc. Magn. Reson. 3:1838

    Google Scholar 

  • Huda, A., Thomas, A., Buze, B., Curran, J., Fairbanks, L., Bugbee, M. and Fawzy, F.I. (1997). MR spectroscopy and neuropsychological characterization of subclinical hepatic encephalopathy: a clinical correlation study [abstract]. Int. Soc. Magn. Reson. Med. 5:533

    Google Scholar 

  • Inoue, E., Hori, S., Narumi, Y., Fujita, M., Kuriyama, K., Kadota, T. and Kuroda, C. (1991). Portal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR images. Radiol. 179:551–555.

    Google Scholar 

  • Kimmich, R. and Hoepfel, D. (1987). Volume selective multipulse spin-echo spectroscopy. J. Magn. Reson. 72:379–384.

    Google Scholar 

  • Köstler, H., Dietrich, B., Ahl, B., Fischer-Wasel, D., Manns, M.P., Becker, H. and Weissenborn, K. (1997). Variations in 1H MRS in patients with portosystemic encephalopathy: dependence on location and clinical status [abstract]. Int. Soc. Magn. Reson. Med. 5:1240.

    Google Scholar 

  • Kreis, R., Farrow, N.A. and Ross, B.D. (1990). Diagnosis of hepatic encephalopathy by proton magnetic resonance spectroscopy. Lancet 336:635–636.

    Google Scholar 

  • Kreis, R., Farrow N. and Ross, B.D. (1991). Localized 1H NMR spectroscopy in patients with chronic hepatic encephalopathy analysis of changes in cerebral glutamine, choline and inositols. NMR in Biomedicine 4:109–116.

    Google Scholar 

  • Kreis, R., Ross, B.D., Farrow, N.A. and Ackerman, Z. (1992). Metabolic disorder of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiol. 182:19–27.

    Google Scholar 

  • Kulisevsky, J., Pujol, J., Balanzo, J., Junque, C., Deus, J., Capdevila, A. and Villanueva, C. (1992). Pallidal hyperintensity on magnetic resonance imaging in cirrhotic patients: clinical correlations. Hepatol. 16:1382–1388.

    Google Scholar 

  • Kulisevsky, J., Pujol, J., Junque, C., Deus, J., Balanzo, J. and Capdevila, A. (1993). MRI pallidial hyperintensity and brain atrophy in cirrhotic patients: Two different MRI patterns of clinical deterioration? Neurol. 43:2570–2573.

    Google Scholar 

  • Laubenberger, J., Häussinger, D., Bayer, S., Gufler, H., Hennig, J. and Langer, M. (1997). Proton magnetic resonance spectroscopy on the brain in symptomatic and asymptomatic patients with liver cirrhosis. Gastroenterol. 112:1610–1616.

    Google Scholar 

  • Laubenberger, J., Bayer, S., Thiel, J., Hennig, J. and Langer, M. (1998). Clinical application of proton magnetic resonance spectroscopy of the brain. Fortschr. Röntgenstr. 168:539–549.

    Google Scholar 

  • Lee, J.H., Choi, C.G., Lee, Y.S., Suh, D.C. and Lim, T.H. (1995). Localized 1H MR spectroscopy of the basal ganglia in liver cirrhosis and hepatic encephalopathy [abstract]. Soc. Magn. Reson. 3:1837.

    Google Scholar 

  • Lockwood, A.H., Yap, E.W.H., Rhoades, H.M. and Wong, W.H. (1991). Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy. J. Cereb. Blood Flow Metab. 11:331–336.

    Google Scholar 

  • Lockwood, A.H., Murphy, B.W., Donnelly, K.Z., Mahl, T.C. and Perini, S. (1993). Positron-emission tomographic localization of abnormalities of brain metabolism in patients with minimal hepatic encephalopathy. Hepatol. 18:1061–1068.

    Google Scholar 

  • Marcus, C.D., Sargentoni, J., Bryant, D.J. and Taylor-Robinson, S.D. (1994). 1H MRS in patients with chronic hepatic encephalopathy — regional variations [abstract]. Soc. Magn. Reson. 2:571.

    Google Scholar 

  • Morgan, M. (1996). Noninvasive neuroinvestigation in liver disease. Semin. Liver Dis. 16:293–314.

    Google Scholar 

  • Nägele, T., Seeger, U., Klose, U., Seitz, D., Viebahn, R., Grodd, W., Voigt, K. (1998). MR imaging and short echo-time localized 1H spectroscopy of the brain in hepatic encephalopathy: follow up after liver transplantation [abstract]. Int. Soc. Magn. Reson. Med. 4:305.

    Google Scholar 

  • Nägele, T., Seeger, U., Klose, U., Seitz, D., Viebahn, R. and Grodd, W. (1997). 1H Spektroskopie des Gehirns zur Verlaufsbeurteilung der hepatischen Enzephalopathie vor und nach Lebertransplantation unter besonderer Ber cksichtigung des Langzeitverlaufs [abstract]. Fortschr. Röntgenstr. 166:S93.

    Google Scholar 

  • Nägele, T., Seeger, U., Klose, U., Britsch, S., Wilms, P., Seitz, D. et al. (1996). Localized 1H spectroscopy of the brain with ultra-short echo times in hepatic encephalopathy including follow up after liver transplantation [abstract]. Int. Soc. Magn. Reson. Med. 6:1747.

    Google Scholar 

  • Norenberg, M.D. and Bender, A.S. (1994). Astrocyte swelling in liver failure: role of glutamine and benzodiazepines. Acta Neurochir. [Suppl] 60:24–27.

    Google Scholar 

  • Pujol, A., Graus, F., Peri, J., Mercader, J.M. and Rimola, A. (1991). Hyperintensity in the globus pallidus on T1-weighted and inversion recovery MRI: a possible marker of advanced liver disease. Neurol. 41:1526–1527.

    Google Scholar 

  • Pujol, A., Pujol, J., Graus, F., Rimola, A., Peri, J., Mercader, J.M. et al. (1993). Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure. Neurol. 43:65–69.

    Google Scholar 

  • Pujol, J., Kulisevski, J., Moreno, A., Deus, J., Alonso, J., Balanzó, J. et al. (1996). Neurospectroscopic alterations and globus pallidus hyperintensity as related magnetic resonance markers of reversible hepatic encephalopathy. Neurol. 47:1526–1530.

    Google Scholar 

  • Raabe W. (1987). Synaptic transmission in ammonia intoxication. Neurochem. Pathol. 6:145–166.

    Google Scholar 

  • Ross, B.D. (1991). Biochemical considerations in 1H spectroscopy. Glutamate and glutamine; myo-inositol and related metabolites. NMR in Biomedicine 4:59–63.

    Google Scholar 

  • Ross, B.D., Shonk, T., Moats, R.A., Jacobson S., Draguesku, J., Ernst, T. et al. (1993a). 1H MRS for the diagnosis of sub-clinical hepatic encephalopathy [abstract]. Soc. Magn. Reson. Med. 12:131.

    Google Scholar 

  • Ross, B.D., Jacobson S., Villamil, F.G., Moats, R.A., Shonk, T. and Draguesku, J. (1993b). Cerebral myo-inositol depletion defines subclinical hepatic encephalopathy [abstract]. Hepatol. 118:105 A.

    Google Scholar 

  • Ross, B.D., Jacobson S., Villamil, F., Korula, J., Kreis, R., Ernst, T. et al. (1994). Subclinical hepatic encephalopathy: Proton MR spectroscopic abnormalities. Radiol. 193:457–463.

    Google Scholar 

  • Ross, B.D. and Michaelis, T. (1994). Clinical applications of magnetic resonance spectroscopy. Magn. Res. Quarterly 10:191–247.

    Google Scholar 

  • Ross, B.D., Katz, M., Kordula, J., Shonk, T., Mandigo, J.C. and Reynolds, T. (1995). Predicting clinical hepatic encephalopathy after tips. [abstract]. Soc. Magn. Reson. 3:1840.

    Google Scholar 

  • Seery, J.P. and Taylor-Robinson, S.D. (1996). The application of magnetic resonance spectroscopy to the study of hepatic encephalopathy. J. Hepatol. 25:988–998.

    Google Scholar 

  • Schenker, S. and Butterworth, R. (1997). NMR spectroscopy in portal-systemic encephalopathy: are we there yet? Gastroenterol. 112:1758–1761.

    Google Scholar 

  • Seo, D.W., Lee, J.H., Kim, S.T., Chung, Y.H., Lee, Y.S. and Lim, T.H. (1997). Proton magnetic resonance spectroscopy findings in patients with liver cirrhosis: decreased myo-inositol/creatine ratio does not reflect the severity of hepatic encephalopathy [abstract]. Int. Soc. Magn. Reson. Med. 5:534

    Google Scholar 

  • Seo, D.W., Lee, J.H., Lee, Y.S., Kim, S.T., Suh, D.J., Min, Y.I. and Lim, T.H. (1998). Proton magnetic resonance spectroscopy findings in cirrhotic patients without overt hepatic encephalopathy: does the myoinositol/creatine ratio reflect hepatic functional reserve? [abstract]. Int. Soc. Magn. Reson. Med. 6:1719.

    Google Scholar 

  • Taylor-Robinson, S.D., Sargentoni, J., Marcus, C.D., Morgan, M.Y. and Bryant, D.J. (1994). Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy. Metab. Brain Dis. 9:347–359.

    Google Scholar 

  • Taylor-Robinson, S.D., Oatridge, A., Hajnal J.V., Burroughs, A.K., McIntyre, N. and deSouza, N.M. (1995). MR imaging of the basal ganglia in chronic liver disease: correlation of T1-weighted and magnetization transfer contrast measurements with liver dysfunction and neuropsychiatric status. Metab. Brain Dis. 10:175–188.

    Google Scholar 

  • Weissenborn, K., Burchert, W., Bokemeyer, M., Ehrenheim, C., Kolbe, H., Manns, M.P. and Dengler, R. (1997). Regional differences of cerebral glucose metabolism in patients with liver cirrhosis depending on the grade of portosystemic encephalopathy (PSE). In (C. Record and H. Al-Mardini, eds.) Advances in Hepatic Encephalopathy and Metabolism in Liver Disease, Medical Faculty University of Newcastle upon Tyne, Newcastle upon Tyne, pp. 359–363.

    Google Scholar 

  • Weissenborn, K. and Kolbe, H. (1998). The basal ganglia and portosystemic encephalopathy. Metab. Brain Dis.(this volume).

  • Zeneroli, M.L. Cioni, G., Crisi, G., Vezzelli, C. and Ventura, E. (1991). Globus pallidus alteration and brain atrophy in liver cirrhosis patients with encephalopathy: A MRI imaging study. Magn. Res. Imaging 9:295–302.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neuroradiology, Medizinische Hochschule Hannover, Hannover, Germany

    Herbert Köstler

Authors
  1. Herbert Köstler
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Köstler, H. Proton Magnetic Resonance Spectroscopy in Portal-Systemic Encephalopathy. Metab Brain Dis 13, 291–301 (1998). https://doi.org/10.1023/A:1020632708154

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020632708154

Search

Navigation